TCL Archive FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight December 17, 2010
TCL Archive Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million January 19, 1979
TCL Archive In Brief: Schepartz To Leave NCI for Academia; Woolley Names To Head Clinical Research At Lombardi March 9, 1984